Hypericin: Difference between revisions
the link was removed |
No edit summary |
||
Line 53: | Line 53: | ||
The crude extract of ''Hypericum'' has weak receptor affinity for [[Monoamine oxidase A|MAO-A]] and [[Monoamine oxidase B|MAO-B]] receptors. Isolated hypericin does not display this activity, but does have affinity for [[NMDA receptor]]s. |
The crude extract of ''Hypericum'' has weak receptor affinity for [[Monoamine oxidase A|MAO-A]] and [[Monoamine oxidase B|MAO-B]] receptors. Isolated hypericin does not display this activity, but does have affinity for [[NMDA receptor]]s. |
||
The large [[chromophore]] system in the molecule means that it can cause [[photosensitivity]] when ingested beyond threshold amounts. Because hypericin accumulates preferentially |
The large [[chromophore]] system in the molecule means that it can cause [[photosensitivity]] when ingested beyond threshold amounts. Photosensitivity is often seen in [[Photosensitivity_in_animals|animals]] that have been allowed to graze on St. John's Wort. Because hypericin accumulates preferentially in [[cancer|cancerous]] tissues, it is also used as an indicator of cancerous cells. In addition, hypericin is under research as an agent in [[photodynamic therapy]], whereby a biochemical is absorbed by an organism to be later activated with spectrum-specific light from specialized lamps or [[laser]] sources, for therapeutic purposes. |
||
==References== |
==References== |
Revision as of 23:50, 10 February 2010
![]() | |
![]() | |
Names | |
---|---|
IUPAC name
1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione
| |
Other names
4,5,7,4',5',7'-Hexahydroxy-2,2'-dimethylnaphthodianthrone
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.008.129 |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
Properties | |
C30H16O8 | |
Molar mass | 504.450 g·mol−1 |
Appearance | Blue-black solid |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Hypericin is a red-coloured anthraquinone-derivative, which, together with hyperforin, is one of the principal active constituents of Hypericum (Saint John's wort).[2] Hypericin is believed to act as an antibiotic and non-specific kinase inhibitor. Hypericin may inhibit the action of the enzyme dopamine β-hydroxylase, leading to increased dopamine levels, although thus possibly decreasing norepinephrine and epinephrine.
The crude extract of Hypericum has weak receptor affinity for MAO-A and MAO-B receptors. Isolated hypericin does not display this activity, but does have affinity for NMDA receptors.
The large chromophore system in the molecule means that it can cause photosensitivity when ingested beyond threshold amounts. Photosensitivity is often seen in animals that have been allowed to graze on St. John's Wort. Because hypericin accumulates preferentially in cancerous tissues, it is also used as an indicator of cancerous cells. In addition, hypericin is under research as an agent in photodynamic therapy, whereby a biochemical is absorbed by an organism to be later activated with spectrum-specific light from specialized lamps or laser sources, for therapeutic purposes.
References
- ^ Merck Index, 11th Edition, 4799
- ^ Oubre, Alondra (1991). "Hypericin: the active ingredient in Saint John's Wort". Retrieved September 18, 2006.
{{cite web}}
: Cite has empty unknown parameters:|month=
and|coauthors=
(help)